Literature DB >> 2182542

Oral vaccination of mice against tetanus by use of a live attenuated Salmonella carrier.

N F Fairweather1, S N Chatfield, A J Makoff, R A Strugnell, J Bester, D J Maskell, G Dougan.   

Abstract

A Salmonella typhimurium aroA mutant has been used as a live carrier to immunize mice against tetanus. Plasmid pTETtac4, which expresses a 50-kilodalton fragment of tetanus toxin (fragment C) under the control of the tac promoter, was introduced into SL3261 aroA. When used as a live vaccine and administered orally or intravenously, this strain was able to induce protective immunity in mice against a lethal tetanus toxin challenge. When plasmid pTETtac2, which contains the lacI gene, was used, no immunity was obtained, indicating that the expression of fragment C was repressed in vivo. We believe that this is the first example of a successful oral vaccination that uses an attenuated bacterial carrier to deliver a protective antigen derived from tetanus toxin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2182542      PMCID: PMC258627          DOI: 10.1128/iai.58.5.1323-1326.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Binding of ganglioside by the chains of tetanus toxin.

Authors:  S van Heyningen
Journal:  FEBS Lett       Date:  1976-09-15       Impact factor: 4.124

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine.

Authors:  R Germanier; E Füer
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

4.  Structure of tetanus toxin. II. Toxin binding to ganglioside.

Authors:  T B Helting; O Zwisler; H Wiegandt
Journal:  J Biol Chem       Date:  1977-01-10       Impact factor: 5.157

5.  Salmonella typhimurium LT2 strains which are r- m+ for all three chromosomally located systems of DNA restriction and modification.

Authors:  L R Bullas; J I Ryu
Journal:  J Bacteriol       Date:  1983-10       Impact factor: 3.490

6.  Structure of tetanus toxin. I. Breakdown of the toxin molecule and discrimination between polypeptide fragments.

Authors:  T B Helting; O Zwisler
Journal:  J Biol Chem       Date:  1977-01-10       Impact factor: 5.157

7.  Naturally acquired antibodies to tetanus toxin in humans and animals from the galápagos islands.

Authors:  R Veronesi; B Bizzini; R Focaccia; A L Coscina; C C Mazza; M T Focaccia; F Carraro; M N Honningman
Journal:  J Infect Dis       Date:  1983-02       Impact factor: 5.226

8.  Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines.

Authors:  S K Hoiseth; B A Stocker
Journal:  Nature       Date:  1981-05-21       Impact factor: 49.962

9.  Vectors bearing a hybrid trp-lac promoter useful for regulated expression of cloned genes in Escherichia coli.

Authors:  E Amann; J Brosius; M Ptashne
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

10.  Oxygen dependence of omeprazole clearance and sulfone and sulfide metabolite formation in the isolated perfused rat liver.

Authors:  P W Angus; G W Mihaly; D J Morgan; R A Smallwood
Journal:  J Pharmacol Exp Ther       Date:  1989-09       Impact factor: 4.030

View more
  33 in total

Review 1.  Enteric pathogens as vaccine vectors for foreign antigen delivery.

Authors:  Camille N Kotton; Elizabeth L Hohmann
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

2.  Studies of immunity and bacterial invasiveness in mice given a recombinant salmonella vector encoding murine interleukin-6.

Authors:  S J Dunstan; A J Ramsay; R A Strugnell
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 3.  Recombinant avirulent salmonellae as oral vaccine carriers.

Authors:  F Schödel
Journal:  Infection       Date:  1992 Jan-Feb       Impact factor: 3.553

Review 4.  Oral delivery of vaccines. Formulation and clinical pharmacokinetic considerations.

Authors:  D T O'Hagan
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

5.  Antibody responses in the lungs of mice following oral immunization with Salmonella typhimurium aroA and invasive Escherichia coli strains expressing the filamentous hemagglutinin of Bordetella pertussis.

Authors:  C A Guzmán; R M Brownlie; J Kadurugamuwa; M J Walker; K N Timmis
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

6.  Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908.

Authors:  E M Barry; O Gomez-Duarte; S Chatfield; R Rappuoli; M Pizza; G Losonsky; J Galen; M M Levine
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

7.  Gamma interferon-independent effects of interleukin-12 on immunity to Salmonella enterica serovar Typhimurium.

Authors:  Jason D Price; Kim R Simpfendorfer; Radhakrishnam R Mantena; James Holden; William R Heath; Nico van Rooijen; Richard A Strugnell; Odilia L C Wijburg
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

8.  Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice.

Authors:  K L Karem; S Chatfield; N Kuklin; B T Rouse
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

9.  Macrophage-inducible expression of a model antigen in Salmonella typhimurium enhances immunogenicity.

Authors:  E L Hohmann; C A Oletta; W P Loomis; S I Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

10.  Expression of the murine interleukin-4 gene in an attenuated aroA strain of Salmonella typhimurium: persistence and immune response in BALB/c mice and susceptibility to macrophage killing.

Authors:  K Denich; P Börlin; P D O'Hanley; M Howard; A W Heath
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.